The metabolic effects of thia fatty acids in rat liver depend on the position of the sulfur atom

Current Opinion in Lipidology

Volumn 13, Issue 3, 2002, Pages 295-304

  Berge, Rolf K ^a   Skorve, Jon ^a   Tronstad, Karl Johan ^a   Berge, Kjetil ^a   Gudbrandsen, Oddrun Anita ^a   Grav, Hans ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND; TETRADECYLTHIOACETIC ACID; UNCLASSIFIED DRUG; 1 (CARBOXYETHYLTHIO)TETRADECANE; 1-(CARBOXYETHYLTHIO)TETRADECANE; 1-(CARBOXYMETHYLTHIO)TETRADECANE; CELL RECEPTOR; CHOLESTEROL; FATTY ACID; GLUCOSE; PROPIONIC ACID DERIVATIVE; SULFIDE; SULFUR; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; CATABOLISM; CELL PROLIFERATION; DRUG ACTIVITY; FATTY ACID METABOLISM; GROWTH INHIBITION; HEART PROTECTION; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC REGULATION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; ANIMAL; BLOOD; CELL DIFFERENTIATION; CHEMISTRY; HOMEOSTASIS; LIVER; METABOLISM; MITOCHONDRION; MOUSE; PHYSIOLOGY; RAT; RESTENOSIS;

ANIMAL; CELL DIFFERENTIATION; CHOLESTEROL; CORONARY RESTENOSIS; FATTY ACIDS; GLUCOSE; HOMEOSTASIS; HUMAN; LIVER; MICE; MITOCHONDRIA; PROPIONIC ACIDS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SULFIDES; SULFUR; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS; ANIMALS; HUMANS;

EID: 0035985746     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.04.007     Document Type: Article

References (76)

1. Importance of n-3 fatty acids in health and disease
2. Conjugated linoleic acid (CLA) reduced abdominal adiposetissue in obese middle-aged men with signs of the metabolic syndrome: A randomised controlled trial
3. Enhanced hepatic fatty acid oxidation and upregulated carnitine palmitoyltransferase II gene expression by methyl 3-thiaoctadeca-6, 9, 12, 15-tetraenoate in rats
4. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure
5. Alkylthio acetic acids (3-thia fatty acids) - A new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues: II. Dose-response studies on hepatic peroxisomal and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats
6. Impact of cytochrome P450 system on lipoprotein metabolism: Effect of abnormal fatty acids (3-thia fatty acids)
7. Thia fatty acids, metabolism and metabolic effects
8. The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: Metabolism and metabolic effects
9. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate
10. Peroxisome proliferating sulfur- and oxy-substituted fatty acid analogues are activated to acyl coenzyme A thioesters
11. Effects of thia-substituted fatty acids on mitochondrial and peroxisomal beta-oxidation: Studies in vivo and in vitro
12. Morphologic effects of sulfur-substituted fatty acids on rat hepatocytes with special reference to proliferation of peroxisomes and mitochondria
13. Up-regulated delta 9-desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: Accumulation of a delta 9-desaturated metabolite of tetradecylthioacetic acid
14. Long-term effect of tetradecylthioacetic acid: A study on plasma lipid profile and fatty acid composition and oxidation in different rat organs
15. Effect of 3-thia fatty acids on the lipid composition of rat liver, lipoproteins, and heart
16. Peroxisome proliferator-activated receptors: From transcriptional control to clinical practice
17. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
18. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
19. Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner
20. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor
21. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation
22. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation
23. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid
24. Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways
25. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha
26. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus
27. Fatty acyl-CoA oxidase activity is induced before long-chain acyl-CoA hydrolase activity and acyl-CoA binding protein in liver of rat treated with peroxisome proliferating 3-thia fatty acids
28. Long-chain acyl-CoA esters and acyl-CoA binding protein are present in the nucleus of rat liver cells
29. Early effects on mitochondrial- and peroxisomal β-oxidation by the hypolipidemic 3-thia fatty acids in rat livers
30. Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats
31. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism
32. Proliferation of mitochondria and gene expression of carnitine palmitoyltransferase and fatty acyl-CoA oxidase in rat skeletal muscle, heart and liver by hypolipidemic fatty acids
33. Transient up-regulation of liver mitochondrial thymidine kinase activity in proliferating mitochondria
34. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil
35. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids
36. Early modulation of genes encoding peroxisomal and mitochondrial beta-oxidation enzymes by 3-thia fatty acids
37. Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation
38. 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver
39. Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression
40. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists
41. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
42. Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance
43. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes
44. Antioxidants and atherosclerotic heart disease
45. Tetradecylthioacetic acid and tetradecylselenoacetic acid inhibit lipid peroxidation and interact with superoxide radical
46. Preparation and NMR studies of 3-selenaheptadecanoic and 4-selenaoctadecanoic acid, RSe(CH2)nC(O)OH (R=C14H29, n = 1 and 2), and their methyl ester
47. Inhibition of rat lipoprotein oxidation after tetradecylthioacetic acid feeding
48. Changes in mitochondrial and microsomal lipid peroxidation and fatty acid profiles in adrenal glands, testes, and livers from alpha-tocopherol-deficient rats
49. Essential fatty acids: Molecular and cellular basis of their anti-cancer action and clinical implications
50. Eicosapentaenoic acid and sulfur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture
51. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells
52. Growth reduction in glioma cells after treatment with tetradecylthioacetic acid: Changes in fatty acid metabolism and oxidative status
53. Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth
54. Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886
55. Sensitivity of respiratory chain activities to lipid peroxidation: Effect of vitamin E deficiency
56. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
57. Peroxisome proliferator-activated receptors in endothelial cell biology
58. Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig
59. Dietary polyunsaturated fatty acids and inflammatory mediator production
60. A novel long chain polyunsaturated fatty acid, beta-oxa 21:3n-3, inhibits T lymphocyte proliferation, cytokine production, delayed-type hypersensitivity, and carrageenan-induced paw reaction and selectively targets intracellular signals
61. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium
62. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice
63. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)
64. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression: Evidence of inflammatory responses in coronary angioplasty
65. Reactive oxygen species, cell signaling, and cell injury
66. Tetradecylthioacetic acid reduces stenosis development after balloon angioplasty injury of rabbit iliac arteries
67. Long-term retention of a novel antioxidant sulfur-substituted fatty acid analogue after local delivery in porcine coronary arteries
68. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet
69. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP
70. Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine
71. Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia
72. Acyl-CoA: Cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice
73. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
74. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors
75. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression
76. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans